SCHEMBL932990

SCHEMBL932990

Cc1ccc(OC(C=O)N2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PKM P14618 9/20 0.62
LMNA P02545 4/20 0.62
SMN1; SMN2 Q16637 3/20 0.62
HTT P42858 2/20 0.62
MCOLN3 Q8TDD5 3/20 0.53
TSHR P16473 2/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
ALDH1A1 P00352 2/20 0.52
PABPC1 P11940 1/20 0.51
APOBEC3A P31941 1/20 0.51
EIF4H Q15056 1/20 0.51
APOBEC3G Q9HC16 1/20 0.51
GAA P10253 1/20 0.47
PKLR P30613 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932971 0.91 MCOLN3 (0.58) PKMLMNASMN1; SMN2HTTMCOLN3
SCHEMBL933278 0.89 KMT2A (0.54) PKMLMNASMN1; SMN2HTTMCOLN3
SCHEMBL932415 0.84 LMNA (0.53) PKMLMNASMN1; SMN2HTTMCOLN3
SCHEMBL932085 0.82 SMN1; SMN2 (0.55) PKMLMNASMN1; SMN2HTTMCOLN3
SCHEMBL932795 0.82 LMNA (0.42) PKMLMNASMN1; SMN2HTTMEN1
SCHEMBL932174 0.80 MCOLN3 (0.50) PKMLMNASMN1; SMN2HTTMCOLN3
SCHEMBL932284 0.80 PKM (0.61) PKMLMNASMN1; SMN2HTTMCOLN3
SCHEMBL932192 0.79 PKM (0.52) PKMLMNASMN1; SMN2HTTMCOLN3
SCHEMBL932636 0.79 ALDH1A1 (0.50) PKMLMNASMN1; SMN2MEN1KMT2A
SCHEMBL931956 0.78 MEN1 (0.53) PKMLMNASMN1; SMN2HTTMCOLN3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448581-A1 THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USE Agios Pharmaceuticals, Inc. (US) 2012-05-09 EP disclosed
WO-2011002816-A1 THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USE AGIOS PHARMACEUTICALS, INC. (US) 2011-01-06 WO disclosed